P

Pharming Group
PHARM

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€661.36M
EV
€673.54M
Shares Outstanding
687.96M
Beta
0.54

Wall Street View

Analyst Rating
BUY
Analyst Target Price
€1.90
P/E 2025E
-
P/Revenue 2025E
2.24x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Pharming Group N.V.

gainify

P

Pharming Group N.V.

PHARM

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 este...

Sector

Healthcare

Industry

Biotechnology

CEO

de Vries, Sijmen

Employees

404

IPO Date

1999-06-16

Headquarters

Darwinweg 24, Leiden, Zuid-Holland, 2333 CR, Netherlands

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.